HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.

Abstract
Sarcomas are a heterogeneous group of malignancies with mesenchymal lineage differentiation. The discovery of neurotrophic tyrosine receptor kinase (NTRK) gene fusions as tissue-agnostic oncogenic drivers has led to new personalized therapies for a subset of patients with sarcoma in the form of tropomyosin receptor kinase (TRK) inhibitors. NTRK gene rearrangements and fusion transcripts can be detected with different molecular pathology techniques, while TRK protein expression can be demonstrated with immunohistochemistry. The rarity and diagnostic complexity of NTRK gene fusions raise a number of questions and challenges for clinicians. To address these challenges, the World Sarcoma Network convened two meetings of expert adult oncologists and pathologists and subsequently developed this article to provide practical guidance on the management of patients with sarcoma harboring NTRK gene fusions. We propose a diagnostic strategy that considers disease stage and histologic and molecular subtypes to facilitate routine testing for TRK expression and subsequent testing for NTRK gene fusions.
AuthorsG D Demetri, C R Antonescu, B Bjerkehagen, J V M G Bovée, K Boye, M Chacón, A P Dei Tos, J Desai, J A Fletcher, H Gelderblom, S George, A Gronchi, R L Haas, N Hindi, P Hohenberger, H Joensuu, R L Jones, I Judson, Y-K Kang, A Kawai, A J Lazar, A Le Cesne, R Maestro, R G Maki, J Martín, S Patel, F Penault-Llorca, C Premanand Raut, P Rutkowski, A Safwat, M Sbaraglia, I-M Schaefer, L Shen, C Serrano, P Schöffski, S Stacchiotti, K Sundby Hall, W D Tap, D M Thomas, J Trent, C Valverde, W T A van der Graaf, M von Mehren, A Wagner, E Wardelmann, Y Naito, J Zalcberg, J-Y Blay
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 31 Issue 11 Pg. 1506-1517 (11 2020) ISSN: 1569-8041 [Electronic] England
PMID32891793 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Chemical References
  • Oncogene Proteins, Fusion
  • Protein Kinase Inhibitors
  • Tropomyosin
  • Receptor, trkA
Topics
  • Adult
  • Gene Fusion
  • Humans
  • Oncogene Proteins, Fusion (genetics)
  • Protein Kinase Inhibitors
  • Receptor, trkA (genetics)
  • Sarcoma (diagnosis, drug therapy, genetics)
  • Tropomyosin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: